TGA
Meds shortages roundup
Codeine product shortages are winding up while other medicines are set to experience longer delays Four codeine products recently experienced shortages due to increased demand following the February upschedule, as …
Check colour of Valpam 5 tablets
The TGA and Arrow Pharma have issued a product defect alert for a batch of Valpam 5 for potentially containing lower strength tablets The alert is due to the possibility …
‘Wake-up call’ for real time monitoring
Pharmacy and medical bodies have written to the TGA, calling for national script monitoring to be implemented urgently In its consultation paper on options for a regulatory response regarding prescription …
Changes to S8 pack sizes on the cards?
PSA and SHPA are at odds with the Guild in their support of changes to pack sizes, while some pharmacists have voiced concerns about stock management, logistics and cost The …
CHOICE calls out supplement claims
The consumer association is urging Federal Senators to block proposed legislation that would legalise dangerous claims on complementary medicine CHOICE will be in Canberra on Tuesday calling on Federal Senators …
Consumers warned on illegal cannabidiol imports
US-based companies have been illegally exporting cannabidiol and hemp products to people in Australia without import permission, the TGA warns The TGA says it is aware of “false and misleading” …
Warning: Lishou Strong Slimming capsules
The TGA has issued a warning to consumers not to take Lishou Strong Slimming capsules The TGA tested a substance labelled “Lishou Strong Slimming” capsules and found that they contained …
Shortages protocol mooted
A proposed protocol for managing and communicating medicines shortages has the backing of the SHPA Under the changes suggested by the TGA, medicine suppliers would be required to report all …
TGA well trusted by stakeholders: survey
But pharmacists have “fluctuating confidence” in the regulatory body, according to survey results An online survey conducted by the TGA for 2017 has found variation in confidence in the TGA …
EpiPen supply issues to continue indefinitely
While Pfizer is working to achieve ongoing availability, it reportedly cannot commit to a specific time when the supply constraint will be fully resolved Mylan/Alphapharm, the sponsor of EpiPens, has …
Ad mentioning codeine comes under fire
Advertising for an ibuprofen/paracetamol combination painkiller is under investigation, says mainstream media… but are the allegations true? A spokesperson for the Federal Health Department reportedly told the Daily Telegraph that …
Medicine reforms ‘good news’: ASMI CEO
Recent medicine reforms, in particular those for complementary medicines, make manufacturers more accountable for product claims, writes Deon Schoombie Complementary medicines are regulated as medicines under the Therapeutic Goods Act …